<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Korean J Intern Med</journal-id>
      <journal-id journal-id-type="iso-abbrev">Korean J. Intern. Med</journal-id>
      <journal-title-group>
        <journal-title>The Korean Journal of Internal Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1226-3303</issn>
      <issn pub-type="epub">2005-6648</issn>
      <publisher>
        <publisher-name>Korean Association of Internal Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">12014216</article-id>
      <article-id pub-id-type="pmc">4531650</article-id>
      <article-id pub-id-type="doi">10.3904/kjim.2002.17.1.65</article-id>
      <article-id pub-id-type="publisher-id">kjim-17-1-65-12</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>EDTA-dependent Pseudothrombocytopenia Confirmed by Supplementation of Kanamycin; A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Ahn</surname>
            <given-names>Hae Lyun</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af1-kjim-17-1-65-12">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jo</surname>
            <given-names>Young</given-names>
            <suffix>II</suffix>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af1-kjim-17-1-65-12">
            <sup>*</sup>
          </xref>
          <xref ref-type="corresp" rid="c1-kjim-17-1-65-12"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Choi</surname>
            <given-names>Young Suk</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af2-kjim-17-1-65-12">
            <sup>&#x2020;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jung Yeon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af1-kjim-17-1-65-12">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Hae Woon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af1-kjim-17-1-65-12">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Seong Ryul</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af1-kjim-17-1-65-12">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sim</surname>
            <given-names>Joon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af3-kjim-17-1-65-12">
            <sup>&#x2021;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Weon</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af2-kjim-17-1-65-12">
            <sup>&#x2021;</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>Chun Jo</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="af1-kjim-17-1-65-12">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="af1-kjim-17-1-65-12"><label>*</label>Departments of Internal Medicine, Konkuk University College of Medicine, Seoul, Korea</aff>
      <aff id="af2-kjim-17-1-65-12"><label>&#x2020;</label>Clinical Pathology, Konkuk University College of Medicine, Seoul, Korea</aff>
      <aff id="af3-kjim-17-1-65-12"><label>&#x2021;</label>Department of Internal Medicine, Dongbu Municipal Hospital, Seoul, Korea</aff>
      <author-notes>
        <corresp id="c1-kjim-17-1-65-12">Address reprint requests to: Young II Jo, M.D., Department of Internal Medicine, Konkuk University, Minjoong Hospital, 27-1 Hwayang-dong, Gwangjin-gu, Seoul, Korea, 143-180</corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>2002</year>
      </pub-date>
      <volume>17</volume>
      <issue>1</issue>
      <fpage>65</fpage>
      <lpage>68</lpage>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2002 The Korean Association of Internal Medicine</copyright-statement>
        <copyright-year>2002</copyright-year>
        <license>
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>EDTA-dependent pseudothrombocytopenia (PTCP) is the phenomenon of a spurious low platelet count due to EDTA-induced aggregation of platelets. Since the failure to recognize EDTA-dependent PTCP may result in incorrect diagnosis and inappropriate treatment, the recognition of this phenomenon is very important. We report an insidious case of EDTA-dependent PTCP confirmed by supplementation of kanamycin to anticoagulant in a 53-year-old women. Although sodium citrate and heparin usually prevented the aggregation of platelets in EDTA-dependent PTCP patients, these anticoagulants failed in preventing PTCP in our case. EDTA-dependent PTCP was confirmed by the findings that the dumping of platelets on microscopic evaluation was found in EDTA-anticoagulated blood samples, whereas thrombocytopenia and platelet aggregation were not revealed in the sample supplemented with kanamycin.</p>
      </abstract>
      <kwd-group>
        <kwd>Pseudothrombocytopenia</kwd>
        <kwd>EDTA</kwd>
        <kwd>Platelet aggregation</kwd>
        <kwd>Kanamycin</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>EDTA is commonly used as an anticoagulant for blood cell counts, but it may agglutinate the platelets in some patients. This EDTA-induced aggregation of platelets leads to pseudothrombocytopenia, so-called EDTA-dependent PTCP<sup><xref rid="b1-kjim-17-1-65-12" ref-type="bibr">1</xref>)</sup>. EDTA-dependent PTCP can be recognized by the presence of platelet clumps in the peripheral smear of blood anticoagulated with EDTA. The aggregation of platelets in EDTA-dependent PTCP usually is prevented by other anticoagulants, such as sodium citrate or heparin<sup><xref rid="b2-kjim-17-1-65-12" ref-type="bibr">2</xref>)</sup>. In addition, the collection and examination of blood at 37&#xB0;C also prevent the aggregation of platelets<sup><xref rid="b3-kjim-17-1-65-12" ref-type="bibr">3</xref>)</sup>. But, in some cases, platelet aggregation is not completely prevented by these methods for counting the platelets<sup><xref rid="b3-kjim-17-1-65-12" ref-type="bibr">3</xref>,<xref rid="b4-kjim-17-1-65-12" ref-type="bibr">4</xref>)</sup>. Recently, it has been suggested that the supplementation of aminoglycosides to anticoagulant is a useful method for obtaining accurate platelet count in EDTA-dependent PTCP subject<sup><xref rid="b1-kjim-17-1-65-12" ref-type="bibr">1</xref>,<xref rid="b4-kjim-17-1-65-12" ref-type="bibr">4</xref>)</sup>. To the best of our knowledge, this is the first report in Korea of EDTA-dependent PTCP confirmed by the supplementation of kanamycin to anticoagulant in a healthy subject.</p>
    </sec>
    <sec>
      <title>CASE</title>
      <p>A 53-year-old woman was referred to our hospital because of thrombocytopenia detected incidentally. Findings from the general practitioner&#x2019;s laboratory were platelet 19,000/mm<sup>3</sup>, WBC 4,300/mm<sup>3</sup>, Hb 9.4 g/dL and Hct 28.6%. The patient did not use alcohol or any medication. She denied drug and food allergy. There was no family history of hemorrhagic disorders. There was no history of ecchymoses, recent melena, metrorrhagia or weight loss. Neither signs of hemorrhagic diathesis, such as bruises, nor lymphadenopathy were detected on the physical examination.</p>
      <p>The patient&#x2019;s platelet count in our laboratory was 20,000/mm<sup>3</sup> but the aggregation of platelets was recognized by microscopic examination of the peripheral blood smear. We suspected that this low platelet count was due to EDTA-induced aggregation of platelets. So, we measured the platelet count of the patient&#x2019;s blood samples anticoagulated with sodium citrate and heparin. However, the platelet count with sodium citrate and heparin was 45,000/mm<sup>3</sup> and 44,000/mm<sup>3</sup>, respectively. In microscopic examination of the blood smears, the aggeregation of platelets was detected in both blood samples. Anti-platelet antibodies and anti- cardiolipin antibodies were not detectable. To confirm the diagnosis of EDTA-dependent PTCP, we measured the platelet count and examined the blood cell morphology with the EDTA blood supplemented with kanamycin. For the kanamycin-supplemented anticoagulation, 20 mg of kanamycin were added to 2 mg of potassium EDTA either before or 30 min after blood withdrawal. EDTA blood supplemented with kanamycin and blood samples anticoagulated with other anticoagulants, such as EDTA, sodium citrate and heparin, were collected and incubated at room temperature. EDTA-anticoagulated blood was collected and incubated also at 37&#xB0;C. Then, we measured the platelet count and examined the blood cell morphology in all the above-mentioned samples immediately after blood withdrawal and after 30 min, 60 min and 120 min of incubation at room temperature or at 37&#xB0;C (<xref ref-type="fig" rid="f1-kjim-17-1-65-12">Figure 1</xref>). Sodium citrate and heparin failed in preventing the aggregation of platelets in this case. The collection and examination of a sample anticoagulated with EDTA at 37&#xB0;C and the addition of kanamycin to anticoagulant after blood withdrawal only partially prevented the clumping anticoagulant before blood withdrawal resulted in a complete prevention of platelet aggregation (<xref ref-type="fig" rid="f2-kjim-17-1-65-12">Figure 2A, 2B</xref>).</p>
      <p>We confirmed EDTA-dependent PTCP because the aggregation of platelets on microscopic evaluation was found in EDTA-anticoagulated blood samples without the addition of kanamycin, whereas thrombocytopenia and platelet clumping was not revealed in the sample supplemented with kanamycin.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>EDTA-dependent PTCP is the phenomenon of a spurious low platelet count due to the appearance of antiplatelet autoantibodies that cause platelet clumping in blood anticoagulated with EDTA<sup><xref rid="b5-kjim-17-1-65-12" ref-type="bibr">5</xref>,<xref rid="b6-kjim-17-1-65-12" ref-type="bibr">6</xref>)</sup>. These antiplatelet antibodies, usually IgG or IgM, and rarely IgA, recognize platelet antigens on the platelet membrane modified by EDTA<sup><xref rid="b1-kjim-17-1-65-12" ref-type="bibr">1</xref>,<xref rid="b3-kjim-17-1-65-12" ref-type="bibr">3</xref>,<xref rid="b4-kjim-17-1-65-12" ref-type="bibr">4</xref>,<xref rid="b7-kjim-17-1-65-12" ref-type="bibr">7</xref>)</sup>. The platelet membrane glycoprotein complex IIb/IIIa might be involved in EDTA-dependent antibody reaction<sup><xref rid="b3-kjim-17-1-65-12" ref-type="bibr">3</xref>)</sup>. The GP lib fraction is normally hidden in GP IIb/IIIa complex, but becomes accessible to the cold antibody after dissociation of the glycoprotein complex due to the chelating effect of EDTA on calcium ions, which are associated with alterations in protein conformation caused by low temperature<sup><xref rid="b3-kjim-17-1-65-12" ref-type="bibr">3</xref>,<xref rid="b8-kjim-17-1-65-12" ref-type="bibr">8</xref>,<xref rid="b9-kjim-17-1-65-12" ref-type="bibr">9</xref>)</sup>.</p>
      <p>A spurious low platelet count due to platelet aggregation in EDTA-dependent PTCP is of practical importance because the lack of recognition of this clinical entity may result in erroneous diagnosis and subsequent mismanagement of the patient<sup><xref rid="b1-kjim-17-1-65-12" ref-type="bibr">1</xref>,<xref rid="b10-kjim-17-1-65-12" ref-type="bibr">10</xref>)</sup>. So, the first step in any case of newly diagnosed thrombocytopenia is to rule out falsely low platelet counts resulting from cold reactive, EDTA-dependent antiplatelet autoantibodies<sup><xref rid="b6-kjim-17-1-65-12" ref-type="bibr">6</xref>,<xref rid="b11-kjim-17-1-65-12" ref-type="bibr">11</xref>)</sup>. The EDTA-dependent PTCP can be confirmed by microscopic evaluation of a peripheral blood smear for aggregation of platelets and difference in platelet counts between EDTA and other anticoagulants<sup><xref rid="b5-kjim-17-1-65-12" ref-type="bibr">5</xref>,<xref rid="b9-kjim-17-1-65-12" ref-type="bibr">9</xref>,<xref rid="b11-kjim-17-1-65-12" ref-type="bibr">11</xref>)</sup>. Anticoagulants, such as heparin and sodium citrate, are usually used for obtaining accurate platelet counts in EDTA-dependent PTCP patients<sup><xref rid="b2-kjim-17-1-65-12" ref-type="bibr">2</xref>,<xref rid="b12-kjim-17-1-65-12" ref-type="bibr">12</xref>)</sup>. But, as in this case, platelet clumpings may be observed also in a blood sample anticoagulated with sodium citrate and heparin<sup><xref rid="b3-kjim-17-1-65-12" ref-type="bibr">3</xref>,<xref rid="b13-kjim-17-1-65-12" ref-type="bibr">13</xref>,<xref rid="b14-kjim-17-1-65-12" ref-type="bibr">14</xref>)</sup>. Therefore, various methods for obtaining accurate platelet count in such PTCP patients have been suggested.</p>
      <p>It has been suggested that the best and most rapid technique for obtaining accurate platelet counts in EDTA-dependent PTCP patients was to collect and examine EDTA-anticoagulated blood at 37&#xB0;C<sup><xref rid="b3-kjim-17-1-65-12" ref-type="bibr">3</xref>)</sup>. However, as in this case, platelet clumpings will still be present in about 20% of these patients. In the cases that show clumping also at 37&#xB0;C, the examination of blood anticoagulated with ammonium oxalate in a Bucker chamber was recommended for proving PTCP<sup><xref rid="b3-kjim-17-1-65-12" ref-type="bibr">3</xref>)</sup>. It has been demonstrated that platelets could be counted correctly by the addition of a high concentration of sodium fluoride (NaF) in EDTA-anticoagulated blood in the patients with EDTA- dependent PTCP<sup><xref rid="b13-kjim-17-1-65-12" ref-type="bibr">13</xref>)</sup>.</p>
      <p>Sakurai et al. reported that the prior addition of aminoglycosides to anticoagulants completely prevented the aggregation of platelets in EDTA-dependent PTCP subjects although the mode of action is not known<sup><xref rid="b1-kjim-17-1-65-12" ref-type="bibr">1</xref>)</sup>. In addition, the supplementation of aminoglycosides to EDTA-anticoagulated samples after blood withdrawal induced dissociation of aggregated platelets in blood samples from patients with EDTA-dependent PTCP<sup><xref rid="b1-kjim-17-1-65-12" ref-type="bibr">1</xref>,<xref rid="b5-kjim-17-1-65-12" ref-type="bibr">5</xref>,<xref rid="b6-kjim-17-1-65-12" ref-type="bibr">6</xref>)</sup>. So, it has been suggested that the supplementation of aminoglycosides to samples from EDTA-dependent PTCP patients, either before or after blood withdrawal, is an easy and effective way to diagnose EDTA-dependent PTCP and accuratley evaluate the platelet count of PTCP patients<sup><xref rid="b1-kjim-17-1-65-12" ref-type="bibr">1</xref>)</sup>.</p>
      <p>In this case, we examined whether platelet clumping was prevented by the use of sodium citrate and heparin as a anticoagulant, by the addition of kanamycin to EDTA-anticoagulated sample before and after blood withdrawal and by the collection and examination of EDTA-anticoagulated blood at 37&#xB0;C. While sodium citrate and heparin failed in preventing pseudothrombocytopenia, the addition of kanamycin to EDTA-anticoagulated sample after blood withdrawal and the collection and examination of samples at 37&#xB0;C only partially prevented the aggregation of platelets. But, pre-supplementation of kanamycin to EDTA before blood sampling resulted in a complete prevention of platelet aggregation and pseudothrombocytopenia.</p>
      <p>The findings in this case are most consistent with those of Sakurai et al. that the prior addition of aminoglycosides to EDTA completely prevented the aggregation of platelets<sup><xref rid="b1-kjim-17-1-65-12" ref-type="bibr">1</xref>)</sup>. In conclusion, although the precise mechanism by which aminoglycosides prevent the aggregation of platelets is unknown, the pre-supplementation of aminoglycoside antibiotics such as kanamycin to EDTA before the sample withdrawal is an easy and effective method for obtaining accurate platelet counts in patients with EDTA-dependent PTCP.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1-kjim-17-1-65-12">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sakurai</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shiojima</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Tanigawa</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakahara</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Aminoglycosides prevent and dissociate the aggregation of platelet in patients with EDTA-dependent pseudothrombocytopenia</article-title>
          <source>Br J Haematol</source>
          <volume>99</volume>
          <fpage>817</fpage>
          <lpage>823</lpage>
          <year>1997</year>
          <pub-id pub-id-type="pmid">9432027</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-kjim-17-1-65-12">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lombarts</surname>
              <given-names>AJPF</given-names>
            </name>
            <name>
              <surname>de Kieviet</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>Recognition and prevention of pseudothrombocytopenia and concomitant pseudoleukocytosis</article-title>
          <source>Am J Clin Pathol</source>
          <volume>89</volume>
          <fpage>634</fpage>
          <lpage>639</lpage>
          <year>1988</year>
          <pub-id pub-id-type="pmid">3128946</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-kjim-17-1-65-12">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bizzaro</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>EDTA-dependent pseudothrombocytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up</article-title>
          <source>Am J Hematol</source>
          <volume>50</volume>
          <fpage>103</fpage>
          <lpage>109</lpage>
          <year>1995</year>
          <pub-id pub-id-type="pmid">7572988</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-kjim-17-1-65-12">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fiorin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Steffan</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pradella</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bizzaro</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Potenza</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>De Angelis</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>IgG platelet antibodies in EDTA-dependent pseudothrombocytopenia bind to platelet membrane glycoprotein lib</article-title>
          <source>Am J Clin Pathol</source>
          <volume>110</volume>
          <fpage>178</fpage>
          <lpage>183</lpage>
          <year>1998</year>
          <pub-id pub-id-type="pmid">9704616</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-kjim-17-1-65-12">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lombarts</surname>
              <given-names>AJPF</given-names>
            </name>
            <name>
              <surname>Zijlstra</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>RHM</given-names>
            </name>
            <name>
              <surname>Thomasson</surname>
              <given-names>CG</given-names>
            </name>
            <name>
              <surname>Franck</surname>
              <given-names>PFH</given-names>
            </name>
          </person-group>
          <article-title>Accurate platelet counting in an insidious case of pseudothrombocytopenia</article-title>
          <source>Clinic Chem Lab Med</source>
          <volume>37</volume>
          <fpage>1063</fpage>
          <lpage>1066</lpage>
          <year>1999</year>
        </element-citation>
      </ref>
      <ref id="b6-kjim-17-1-65-12">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kudo</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Yoshitake</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shinguu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Noguchi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Transient EDTA-dependent pseudothrombocytopenia in a patient with sepsis</article-title>
          <source>Intensive care med</source>
          <volume>26</volume>
          <fpage>218</fpage>
          <lpage>220</lpage>
          <year>2000</year>
          <pub-id pub-id-type="pmid">10784313</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-kjim-17-1-65-12">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pegels</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Bruynes</surname>
              <given-names>EC</given-names>
            </name>
            <name>
              <surname>Engelfriet</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>von dem Borne</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Pseudothrombocytopenia: an immunologic study on platelet antibodies dependent on ethylene diamine tetraacetate</article-title>
          <source>Blood</source>
          <volume>59</volume>
          <fpage>157</fpage>
          <lpage>161</lpage>
          <year>1982</year>
          <pub-id pub-id-type="pmid">6797491</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-kjim-17-1-65-12">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bizaro</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Brandalise</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>EDTA-dependent pseudothrombocytopenia associated with antiplatelet and antiphospholipid antibodies</article-title>
          <source>Am J Clin Pathol</source>
          <volume>103</volume>
          <fpage>103</fpage>
          <lpage>107</lpage>
          <year>1995</year>
          <pub-id pub-id-type="pmid">7817934</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-kjim-17-1-65-12">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stiegler</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fischer</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Steiner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Strauer</surname>
              <given-names>BE</given-names>
            </name>
            <name>
              <surname>Reinauer</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab</article-title>
          <source>Ann Hematol</source>
          <volume>79</volume>
          <fpage>161</fpage>
          <lpage>164</lpage>
          <year>2000</year>
          <pub-id pub-id-type="pmid">10803940</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-kjim-17-1-65-12">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berkman</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Michaeli</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Or</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Eldor</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>EDTA-dependent pseudothrombocytopenia: a clinical study of 18 patients and a review of the literature</article-title>
          <source>am J Hematol</source>
          <volume>36</volume>
          <fpage>195</fpage>
          <lpage>201</lpage>
          <year>1991</year>
          <pub-id pub-id-type="pmid">1899964</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-kjim-17-1-65-12">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gschwandtner</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Siostrzonek</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Bodinger</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Neunteufl</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zauner</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Heinz</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Maurer</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Panzer</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Documented sudden onset of pseudothrombocytopenia</article-title>
          <source>Ann Hematol</source>
          <volume>74</volume>
          <fpage>283</fpage>
          <lpage>285</lpage>
          <year>1997</year>
          <pub-id pub-id-type="pmid">9236514</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-kjim-17-1-65-12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edelman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Kickler</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Sequential measurement of antiplatelet antibodies in a patient who developed EDTA-dependent pseudothrombocytopenia</article-title>
          <source>Am J Clin Pathol</source>
          <volume>99</volume>
          <fpage>87</fpage>
          <lpage>89</lpage>
          <year>1993</year>
          <pub-id pub-id-type="pmid">8422023</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-kjim-17-1-65-12">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kabutomori</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Koh</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Amino</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>&#x201C;Correct&#x201D; platelet count in EDTA-dependent pseudothrombocytopenia</article-title>
          <source>Eur J Haematol</source>
          <volume>55</volume>
          <fpage>67</fpage>
          <lpage>68</lpage>
          <year>1995</year>
          <pub-id pub-id-type="pmid">7615055</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-kjim-17-1-65-12">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Savage</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Pseudoteukocytosis due to EDTA-induced platelet dumping</article-title>
          <source>Am J Clin Pathol</source>
          <volume>81</volume>
          <fpage>317</fpage>
          <lpage>322</lpage>
          <year>1984</year>
          <pub-id pub-id-type="pmid">6422738</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-kjim-17-1-65-12" orientation="portrait" position="float">
      <label>Figure 1.</label>
      <caption>
        <p>Platelet concentrations measured at different times in blood samples with different anticoagulants. (KM; Kanamycin, Pre-supple.; Pre-supplementation of Kanamycin to EDTA before blood withdrawal, Post-supple.; Post-supplementation of kanamycin to EDTA blood after 30 min of sampling, RT; room temperature</p>
      </caption>
      <graphic xlink:href="kjim-17-1-65-12f1"/>
    </fig>
    <fig id="f2-kjim-17-1-65-12" orientation="portrait" position="float">
      <label>Figure 2.</label>
      <caption>
        <p>The blood cell morphology of blood samples. A: Platelet clumps in EDTA-anticoagulated blood without supplementation of kanamycin. B: No platelet clumps in the samples supplemented with kanamycin to EDTA before blood withdrawal.</p>
      </caption>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
